v3.25.2
Segment Information
 12 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
We have two operating segments, which are the Sleep and Breathing Health segment and the Residential Care Software segment. During fiscal year 2025, we renamed our operating segments from Sleep and Respiratory Care to Sleep and Breathing Health and from Software as a Service to Residential Care Software in alignment with our 2030 strategy. There have been no changes in the preparation and disclosure of financial information by operating segment. The identification of operating segments is based on our internal organizational structure and the information regularly reviewed by our Chief Executive Officer, who is our Chief Operating Decision Maker (CODM). Our CODM evaluates segment performance and makes resource allocation decisions based on net revenue and net operating profit. Impacts to segment net operating profit are referenced by our CODM when deciding to enter new markets, launch new products, reinvest profits, acquire or otherwise invest in other companies, and for monitoring actual results against forecasts. The accounting policies of the segments are the same as those described in Note 2 – Summary of Significant Accounting Policies. Segment net sales and segment net operating profit do not include inter-segment profits and revenue is allocated to a geographic area based on where the products are shipped to or where the services are performed.
Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate headquarters costs, stock-based compensation, amortization expense from acquired intangibles, restructuring expenses, field safety notification expenses, acquisition related expenses, net interest expense (income), gains and losses attributable to equity method investments, gains and losses on equity investments, and other, net. We neither discretely allocate assets to our operating segments, nor does our CODM evaluate the operating segments using discrete asset information.
Additionally, effective in the third quarter of fiscal year 2024, we updated the method of attribution of certain costs that are principally managed at the segment level as part of our evaluation of segment operating performance. As a result, certain costs relating to quality and regulatory assurance, commercial legal, operations, sales and marketing, customer service, information technology, and other administrative costs, which were previously included in Corporate costs within our reconciliation of segment operating profit to income before income taxes, are now reported in segment operating results. The financial information presented herein reflects the impact of the preceding reporting change for all periods presented.
The table below presents a reconciliation of net revenues, significant expenses, net operating profit and depreciation and amortization by reportable segments for the years ended June 30, 2025, 2024 and 2023 (in thousands):
202520242023
Net revenue by segment
Sleep and Breathing Health
$4,504,890 $4,101,172 $3,725,017 
Residential Care Software
641,437 584,125 497,976 
Total$5,146,327 $4,685,297 $4,222,993 
Significant segment expenses
Cost of Sales
Sleep and Breathing Health
$1,852,574 $1,782,023 $1,659,037 
Residential Care Software
195,043 190,186 174,718 
Total$2,047,617 $1,972,209 $1,833,755 
Selling, general, and administrative
Sleep and Breathing Health
$491,591 $451,334 $443,467 
Residential Care Software(1)
143,435 143,999 120,483 
Total$635,026 $595,333 $563,950 
Research and development
Sleep and Breathing Health
$196,340 $186,461 $175,393 
Residential Care Software
97,959 95,490 87,120 
Total$294,299 $281,951 $262,513 
Net operating profit by segment
Sleep and Breathing Health
$1,964,385 $1,681,354 $1,447,120 
Residential Care Software
205,000 154,450 115,655 
Total$2,169,385 $1,835,804 $1,562,775 
Reconciling items
Corporate costs$406,114 $357,937 $338,362 
Amortization of acquired intangible assets77,389 79,484 72,416 
Restructuring expenses— 64,228 9,177 
Masks with magnets field safety notification expenses (2)
(1,512)6,351 — 
Astral field safety notification expenses (3)
— 7,911 — 
Acquisition related expenses2,031 — 10,949 
Interest (income) expense, net(4,114)45,708 47,379 
(Gain) loss attributable to equity method investments(3,644)1,848 7,265 
(Gain) loss on equity investments10,299 4,045 (9,922)
Gain on insurance recoveries— — (20,227)
Other, net5,256 3,494 5,712 
Income before income taxes$1,677,566 $1,264,798 $1,101,664 
Depreciation and amortization by segment
Sleep and Breathing Health
$110,543 $86,070 $82,544 
Residential Care Software
9,467 10,241 9,119 
Amortization of acquired intangible assets and corporate assets78,463 80,559 73,493 
Total$198,473 $176,870 $165,156 
(1)     During the fiscal year ended June 30, 2024, we recorded $4.1 million of operating lease right-of-use asset impairments within our Residential Care Software segment. The impairments related to leases for office space and were recorded within selling, general and administrative expenses.
(2)    The masks with magnets field safety notification expenses relate to estimated costs to provide alternative masks to patients in response to updated contraindications for use of masks that incorporate magnets.
(3)    The Astral field safety notification expenses relate to estimated costs associated with the replacement of a certain component in some of our Astral ventilation devices that were manufactured between 2013 to 2019.
The following table summarizes our net revenue disaggregated by segment, product and region for the years ended June 30, 2025, 2024 and 2023 (in thousands):
202520242023
U.S., Canada and Latin America
Devices$1,654,413 $1,522,758 $1,444,361 
Masks and other1,343,101 1,199,798 1,039,026 
Total U.S., Canada and Latin America$2,997,514 $2,722,556 $2,483,387 
Combined Europe, Asia and other markets
Devices$1,010,760 $921,253 $826,341 
Masks and other496,616 457,363 415,289 
Total Combined Europe, Asia and other markets$1,507,376 $1,378,616 $1,241,630 
Global revenue
Devices$2,665,173 $2,444,011 $2,270,702 
Masks and other1,839,717 1,657,161 1,454,315 
Total Sleep and Breathing Health
$4,504,890 $4,101,172 $3,725,017 
Residential Care Software
641,437 584,125 497,976 
Total$5,146,327 $4,685,297 $4,222,993 
Revenue information by geographic area for the years ended June 30, 2025, 2024 and 2023 is summarized below (in thousands):
202520242023
United States$3,285,581 $2,980,053 $2,719,923 
Rest of the World1,860,746 1,705,244 1,503,070 
Total$5,146,327 $4,685,297 $4,222,993 
Long-lived assets of geographic areas are those assets used in our operations in each geographical area, and excludes goodwill, other intangible assets, and deferred tax assets. Long-lived assets by geographic area as of June 30, 2025 and 2024 is summarized below (in thousands):
20252024
Australia$170,836 $197,017 
United States180,770 160,606 
Singapore98,509 89,679 
Rest of the World100,675 100,723 
Total$550,790 $548,025